Clinical Trial: Effect of Fufang E'Jiao Jiang on Hierarchical Composite Clinical Benefit and Health-related Quality of Life in ICU Survivors After ICU Discharge: a Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial

U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07936760) titled 'Effect of Fufang E'Jiao Jiang on Hierarchical Composite Clinical Benefit and Health-related Quality of Life in ICU Survivors After ICU Discharge: a Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial' on Oct. 29.

Brief Summary: This study aims to evaluate the effects of Fufang E'jiao Jiang on clinical outcomes, health-related quality of life, and functional recovery in survivors of critical illness following intensive care unit (ICU) discharge.This multicenter, randomized, double-blind, placebo-controlled trial will enroll 246 participants who will be randomly assigned in a 1:1 ratio to receive either Fufang E'j...